BG
| |
Bellevue Group AG13F | |
| Bellevue Group AG | |
| Last update 2025-02-16 | 161 Stocks (12 new) |
| Value $5.20 Bil | Turnover 3 % |
Bellevue Group AG Top Holdings of 2024-12-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | argenx SE | 593,184 | 364,808.2 | -6.26% | 7.020 | -0.35% | 0.980 | -1.41% | 0% | 37,661.6 | Biotechnology | |
IONS | Ionis Pharmaceuticals Inc | 7,868,700 | 275,089.8 | -0.07% | 5.300 | 0% | 4.980 | -7.66% | -5.89% | 5,229.9 | Biotechnology | |
NBIX | Neurocrine Biosciences Inc | 1,820,000 | 248,430.0 | -2.35% | 4.780 | -0.08% | 1.830 | -17.30% | -17.96% | 11,165.8 | Drug Manufacturers | |
ISRG | Intuitive Surgical Inc | 464,377 | 242,386.2 | -6.52% | 4.670 | -0.26% | 0.130 | -6.09% | -5.65% | 176,446.6 | Medical Devices & Instruments | |
ITCI | Intra-Cellular Therapies Inc | 2,440,240 | 203,808.9 | -1.83% | 3.920 | -0.05% | 2.300 | +57.72% | +57.59% | 14,020.4 | Drug Manufacturers | |
VRTX | Vertex Pharmaceuticals Inc | 487,434 | 196,289.7 | -14.70% | 3.780 | -0.63% | 0.190 | +26.66% | +24.96% | 129,216.7 | Biotechnology | |
RVMD | Revolution Medicines Inc | 4,386,900 | 191,883.0 | -9.95% | 3.690 | -0.36% | 2.370 | -13.41% | -12.78% | 7,092.6 | Biotechnology | |
ABT | Abbott Laboratories | 1,688,660 | 191,004.3 | -3.17% | 3.680 | -0.10% | 0.100 | +11.18% | +12.28% | 219,114.4 | Medical Devices & Instruments | |
BSX | Boston Scientific Corp | 2,135,295 | 190,724.5 | -12.94% | 3.670 | -0.43% | 0.140 | +13.20% | +12.73% | 148,927.6 | Medical Devices & Instruments | |
SYK | Stryker Corp | 520,026 | 187,235.4 | -1.25% | 3.600 | -0.04% | 0.140 | +2.02% | +3.07% | 141,607.8 | Medical Devices & Instruments |
Bellevue Group AG's Historical Top Holdings Breakdowns
Bellevue Group AG's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
CDNA | CareDx Inc | 2024-12-31 | Reduce | -0.90% | 20.4 ($24.22) 32.2 | $19.32 | -20.23% | Reduce -56.3% | 1,374,412 | -1,771,044 | |
OPCH | Option Care Health Inc | 2024-12-31 | Sold Out | -0.84% | 21.74 ($25.2) 31.64 | $34.56 | 37.14% | Sold Out | 0 | -1,654,878 | |
EXAS | Exact Sciences Corp | 2024-12-31 | Reduce | -0.83% | 49.33 ($62.14) 71.93 | $45.62 | -26.59% | Reduce -52.12% | 694,056 | -755,409 | |
EPIX | ESSA Pharma Inc | 2024-12-31 | Sold Out | -0.77% | 1.4 ($3.14) 6.23 | $1.57 | -50.00% | Sold Out | 0 | -7,879,583 | |
TNDM | Tandem Diabetes Care Inc | 2024-12-31 | Reduce | -0.73% | 27.34 ($33.71) 41.78 | $20.29 | -39.81% | Reduce -57.73% | 782,456 | -1,068,435 | |
EVH | Evolent Health Inc | 2024-12-31 | Reduce | -0.71% | 10.71 ($17.42) 27.13 | $9.58 | -45.01% | Reduce -58.29% | 1,113,658 | -1,556,392 | |
EXEL | Exelixis Inc | 2024-12-31 | Sold Out | -0.67% | 25.39 ($32.54) 36.46 | $36.94 | 13.52% | Sold Out | 0 | -1,600,000 | |
VRTX | Vertex Pharmaceuticals Inc | 2024-12-31 | Reduce | -0.63% | 396.64 ($463.43) 516.74 | $503.20 | 8.58% | Reduce -14.7% | 487,434 | -83,972 | |
UNH | UnitedHealth Group Inc | 2024-12-31 | Reduce | -0.62% | 485.52 ($567.94) 625.25 | $516.85 | -9.00% | Reduce -29.19% | 159,713 | -65,837 | |
CRSP | CRISPR Therapeutics AG | 2024-12-31 | Sold Out | -0.46% | 38.65 ($47.25) 55.15 | $41.22 | -12.76% | Sold Out | 0 | -610,000 |
Bellevue Group AG Total Holding History ($B)
Bellevue Group AG's Asset Allocation
Bellevue Group AG Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Bellevue Group AG's Hypothetical Growth since 2024-12-31
Bellevue Group AG's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Bellevue Group AG's Holdings Heat Map
Size field:
Bellevue Group AG's Holdings Bubble Chart
Bellevue Group AG News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers